Diagnostic utility of the physical examination for pulmonary hypertension

Kevin Solverson (Calgary, Canada), Kevin Solverson, Daniel Vis, Micheal Braganza, Jeff Shaw, Luke Rannelli, Mitesh Thakrar, Rhea Varughese, Naushad Hirani, Doug Helmersen, Jason Weatherald

Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Session: Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Session type: Thematic Poster
Number: 2480
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Abstract

Background and ObjectiveLittle is known about the utility of physical examination (PE) findings in patients with suspected pulmonary hypertension (PH) in the modern era. We aimed to determine the diagnostic utility of commonly referenced PE findings for PH when compared to the gold standard, right heart catheterization (RHC)MethodsSequential patients undergoing RHC at the PH clinic in Calgary, Canada were prospectively enrolled and examined by a respirologist within 60 minutes of RHC. Examiners were blinded to indication and diagnosis. Examiners determined presence or absence of: high jugular venous pressure (JVP)>3cm, palpable P2, parasternal heave, abdominal-jugular reflex (AJR), loud P2, P2 louder than A2 (P2>A2), right-sided S3, and extra-physiologic splitting of S2. PE findings were compared to RHC to determine the sensitivity (Sn), specificity (Sp), positive (+LR) and negative likelihood ratio (-LR) values for identifying PH (mPAP³25mmHg).Results105 patients were enrolled. 66% were female with a median age of 61 (Interquartile Range 28-85). 13 patients (12%) did not have PH (mPAP <25 mmHg). The diagnostic performances of PE findings are displayed in Table 1.

Table 1
Examination Finding Sn Sp +LR (95%CI) -LR(95%CI)
JVP>3cm70672.1 (0.9-4.7)0.45 (0.27-0.76)
Palpable P231620.82 (0.38-1.7)1.1 (0.7-1.7)
Parasternal heave40791.8 (0.63-4.9)0.77 (0.55-1.1)
AJR55691.8 (0.77-4.1)0.66 (0.42-1.0)
Loud P281311.2 (0.8-1.7)0.6 (0.24-1.5)
P2>A266541.4 (0.8-2.6)0.6 (0.24-1.5)
Right-sided S315922.0 (0.3-13.8)0.91 (0.8-1.1)
Extra-physiologic Split S221922.7 (0.4-18.6)0.86 (0.7-1.0)
 
ConclusionsThe physical examination has inadequate diagnostic utility in detecting or excluding the presence of PH.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kevin Solverson (Calgary, Canada), Kevin Solverson, Daniel Vis, Micheal Braganza, Jeff Shaw, Luke Rannelli, Mitesh Thakrar, Rhea Varughese, Naushad Hirani, Doug Helmersen, Jason Weatherald. Diagnostic utility of the physical examination for pulmonary hypertension. Eur Respir J 2016; 48: Suppl. 60, 2480

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Hemodynamic and clinical relevance of “borderline pulmonary hypertension“
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Value of chest radiography in predicting pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013

Diagnostic accuracy of echocardiography in pulmonary hypertension due to interstitial lung disease
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018

Screening pulmonary hypertension by lung doppler signal: A proof-of-concept study
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015

A noninvasive algorithm to exclude pre-capillary pulmonary hypertension
Source: Eur Respir J 2011; 37: 1096-1103
Year: 2011



Lack correlation between FVC/DLC index and pulmonary hypertension in non sclerodermic patients
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015

Criteria for diagnosis of exercise pulmonary hypertension
Source: Eur Respir J 2015; 46: 728-737
Year: 2015



Clinical features of pulmonary hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014



Clinical features of pulmonary hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

Clinical features of pulmonary hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

Single center experience with systematic diagnostic and predictive genetic screening for pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Simple, non-invasive methods to assess severity of pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015


Evaluation of diagnostic methods in pulmonary sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 539s
Year: 2006

Pulmonary hypertension in idiopathic pulmonary fibrosis: Utility of HRCT
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014

Quantitative evaluation of ventilation-perfusion heterogeneity in precapillary pulmonary hypertension with SPECT scintigraphy
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015

About cardiac output assessment in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Relevance of echocardiographic composite index to improve the detection of pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Value of pulmonary intravascular ultrasound in primary pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 2s
Year: 2001